01—History
Free Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $465.4M
YoY changeLargest recent move−84.2%in FY16Latest +1192.7%
3 older moves run past ±150% (largest +1192.7%); point at, tap or drag across the bars to read one.
02—Ledger
Free Cash Flow, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $465.4M | +1192.7% | 10-K | |
| FY2024 | −$42.6M | −201.5% | 10-K | |
| FY2023 | $41.9M | +106.8% | 10-K | |
| FY2022 | −$613.3M | +14.6% | 10-K | |
| FY2021 | −$718.1M | −4.8% | 10-K | |
| FY2020 | −$685.3M | −63.7% | 10-K | |
| FY2019 | −$418.6M | +39.3% | 10-K | |
| FY2018 | −$689.5M | −41.6% | 10-K | |
| FY2017 | −$487.0M | −30.8% | 10-K | |
| FY2016 | −$372.3M | −84.2% | 10-K | |
| FY2015 | −$202.1M | −15.7% | 10-K | |
| FY2014 | −$174.6M | −140.3% | 10-K | |
| FY2013 | −$72.7M | +41.4% | 10-K | |
| FY2012 | −$124.0M | −40.3% | 10-K | |
| FY2011 | −$88.4M | +0.8% | 10-K | |
| FY2010 | −$89.1M | −15.5% | 10-K | |
| FY2009 | −$77.1M | −240.9% | 10-K | |
| FY2008 | $54.7M | — | 10-K |
03—Questions
What is ALNYLAM PHARMACEUTICALS, INC.'s current free cash flow?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual free cash flow for 2025 was $465.4M, a 1192.73% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. free cash flow for the quarter ending December 31, 2025 was $140.3M.
What was ALNYLAM PHARMACEUTICALS, INC.'s free cash flow in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual free cash flow for 2024 was $-42.6M, a 201.54% decline from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s free cash flow in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual free cash flow for 2023 was $41.9M, a 106.84% increase from 2022.
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Ticker
- ALNY
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations